The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation

被引：51

作者：

Bibbins-Domingo, Kirsten ^{[1
]}

Heiman, Alex ^{[2
]}

Dzau, Victor J. ^{[3
]}

机构：

[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA

[2] Natl Acad Sci Engn & Med, Washington, DC USA

[3] Natl Acad Med, Washington, DC USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 23期

关键词：

D O I：

10.1001/jama.2022.9083

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint summarizes a report from the National Academies of Sciences, Engineering, and Medicine that details the suboptimal inclusion of women and underrepresented racial and ethnic groups in US research studies and provides approaches to better elucidate barriers, facilitators, and best practices in this endeavor.

引用

页码：2283 / 2284

页数：2